Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menstrugole and Zintoma versus Mefenamic Acid for postpartum pain
IRCT20120215009014N545Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Zintoma and Mefenamic acid in Postpartum pain (PPP) (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Postpartum pain intensity. Started Jan 2025; status: completed.
02
Drugs
ZintomaMefenamic acid
03
Conditions
Postpartum pain (PPP)
Beyond the preview
Go deeper on IRCT20120215009014N545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N545.